{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:46:32Z","timestamp":1786992392618,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jgaronline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jgar.2016.02.007","type":"journal-article","created":{"date-parts":[[2016,4,3]],"date-time":"2016-04-03T14:40:11Z","timestamp":1459694411000},"page":"39-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Low prevalence of clarithromycin-resistant Helicobacter pylori isolates with A2143G point mutation in the 23S rRNA gene in North India"],"prefix":"10.1016","volume":"6","author":[{"given":"Valentina","family":"Gehlot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Mahant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asish Kumar","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawed","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prachetash","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajashree","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2016.02.007_bib0180","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4251\/wjgo.v7.i12.455","article-title":"Helicobacter pylori in gastric carcinogenesis","volume":"7","author":"Ahn","year":"2015","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.jgar.2016.02.007_bib0185","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1365-2036.2011.04887.x","article-title":"Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough","volume":"34","author":"Gisbert","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jgar.2016.02.007_bib0190","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMcp1001110","article-title":"Clinical practice. Helicobacter pylori infection","volume":"362","author":"McColl","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2016.02.007_bib0195","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection\u2014the Maastricht IV\/Florence consensus report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jgar.2016.02.007_bib0200","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1572-0241.2007.01393.x","article-title":"American College of Gastroenterology guideline on the management of Helicobacter pylori infection","volume":"102","author":"Chey","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jgar.2016.02.007_bib0205","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1523-5378.2007.00518.x","article-title":"A report card to grade Helicobacter pylori therapy","volume":"12","author":"Graham","year":"2007","journal-title":"Helicobacter"},{"key":"10.1016\/j.jgar.2016.02.007_bib0210","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1523-5378.2007.00506.x","article-title":"Novel genotypes in Helicobacter pylori involving domain V of the 23S rRNA gene","volume":"12","author":"Garrido","year":"2007","journal-title":"Helicobacter"},{"key":"10.1016\/j.jgar.2016.02.007_bib0215","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1128\/AAC.41.12.2621","article-title":"Cloning and sequence analysis of two copies of a 23S rRNA from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations","volume":"41","author":"Taylor","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2016.02.007_bib0220","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1128\/AAC.40.2.477","article-title":"Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori","volume":"40","author":"Versalovic","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2016.02.007_bib0225","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1128\/AAC.46.12.3765-3769.2002","article-title":"New site of modification of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolates","volume":"46","author":"Fontana","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2016.02.007_bib0230","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1053\/j.gastro.2007.07.008","article-title":"Eradication therapy for Helicobacter pylori","volume":"133","author":"Vakil","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jgar.2016.02.007_bib0235","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2036.2005.02533.x","article-title":"Most Helicobacter pylori strains of Kolkata in India are resistant to metronidazole but susceptible to other drugs commonly used for eradication and ulcer therapy","volume":"22","author":"Datta","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jgar.2016.02.007_bib0240","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1586\/eri.09.113","article-title":"Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents","volume":"8","author":"Boyanova","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jgar.2016.02.007_bib0245","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.1128\/JCM.42.10.4856-4858.2004","article-title":"Antimicrobial susceptibility of Helicobacter pylori strains isolated from Bangladesh","volume":"42","author":"Nahar","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2016.02.007_bib0250","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1523-5378.2010.00788.x","article-title":"The evolution of Helicobacter pylori antibiotics resistance over 10 years in Beijing, China","volume":"15","author":"Gao","year":"2010","journal-title":"Helicobacter"},{"key":"10.1016\/j.jgar.2016.02.007_bib0255","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/hel.12046","article-title":"Antibiotic resistance of Helicobacter pylori isolated in the Southeast Coastal Region of China","volume":"18","author":"Su","year":"2013","journal-title":"Helicobacter"},{"key":"10.1016\/j.jgar.2016.02.007_bib0260","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s00535-012-0731-8","article-title":"Multi-center randomized controlled study to establish the standard third-line regimen for Helicobacter pylori eradication in Japan","volume":"48","author":"Murakami","year":"2013","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jgar.2016.02.007_bib0265","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1523-5378.2009.00714.x","article-title":"Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 to 2008 in Japan","volume":"14","author":"Horiki","year":"2009","journal-title":"Helicobacter"},{"key":"10.1016\/j.jgar.2016.02.007_bib0270","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1128\/JCM.00144-10","article-title":"High prevalence of clarithromycin-resistant Helicobacter pylori strains and risk factors associated with resistance in Madrid, Spain","volume":"48","author":"Agudo","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2016.02.007_bib0275","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.gastrohep.2013.02.006","article-title":"Update on the efficacy of triple therapy for Helicobacter pylori infection and clarithromycin resistance rates in Spain (2007\u20132012)","volume":"36","author":"Molina-Infante","year":"2013","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.jgar.2016.02.007_bib0280","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1046\/j.1440-1746.2003.03174.x","article-title":"Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: multicentric study","volume":"18","author":"Thyagarajan","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jgar.2016.02.007_bib0285","doi-asserted-by":"crossref","first-page":"408","DOI":"10.4103\/0255-0857.142256","article-title":"Emerging antimicrobial resistance pattern of Helicobacter pylori in central Gujarat","volume":"32","author":"Pandya","year":"2014","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.jgar.2016.02.007_bib0290","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1440-1746.2008.05747.x","article-title":"Comparison of endoscopic findings with symptom assessment systems (FSSG and QUEST) for gastroesophageal reflux disease in Japanese centres","volume":"24","author":"Danjo","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jgar.2016.02.007_bib0295","series-title":"Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline\u2014second edition. Document M45-A2","author":"Clinical and Laboratory Standards Institute","year":"2010"},{"key":"10.1016\/j.jgar.2016.02.007_bib0300","series-title":"Breakpoint tables for interpretation of MICs and zone diameters. Version 3.1","author":"European Committee on Antimicrobial Susceptibility Testing","year":"2013"},{"key":"10.1016\/j.jgar.2016.02.007_bib0305","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1093\/nar\/8.19.4321","article-title":"Rapid isolation of high molecular weight plant DNA","volume":"8","author":"Murray","year":"1980","journal-title":"Nucleic Acids Res"},{"issue":"Web Server Issue","key":"10.1016\/j.jgar.2016.02.007_bib0310","doi-asserted-by":"crossref","first-page":"W695","DOI":"10.1093\/nar\/gkq313","article-title":"A new bioinformatics analysis tools framework at EMBL-EBI","volume":"38","author":"Goujon","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"6 Suppl","key":"10.1016\/j.jgar.2016.02.007_bib0315","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1016\/S0016-5085(97)80023-6","article-title":"Can therapy ever been denied for Helicobacter pylori infection?","volume":"113","author":"Graham","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jgar.2016.02.007_bib0320","first-page":"40A","article-title":"Efficacy and tolerability of a short-term low-dose triple therapy for eradication of Helicobacter pylori","volume":"104","author":"Bazzoli","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jgar.2016.02.007_bib0325","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1756283X11432492","article-title":"The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy","volume":"5","author":"M\u00e9graud","year":"2012","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.jgar.2016.02.007_bib0330","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1046\/j.1523-5378.2002.00096.x","article-title":"The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance","volume":"7","author":"Perez Aldana","year":"2002","journal-title":"Helicobacter"},{"key":"10.1016\/j.jgar.2016.02.007_bib0335","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/gut.2003.022111","article-title":"H pylori antibiotic resistance: prevalence, importance, and advances in testing","volume":"53","author":"M\u00e9graud","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.jgar.2016.02.007_bib0340","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archinte.161.9.1217","article-title":"Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States","volume":"161","author":"Osato","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jgar.2016.02.007_bib0345","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.dld.2009.01.001","article-title":"Minimal inhibitory concentration (MIC) values and different point mutations in the 23 S rRNA gene for clarithromycin resistance in Helicobacter pylori","volume":"41","author":"De Francesco","year":"2009","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jgar.2016.02.007_bib0350","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1128\/AAC.48.9.3567-3569.2004","article-title":"T2182C mutation in 23S rRNA is associated with clarithromycin resistance in Helicobacter pylori isolates obtained in Bangladesh","volume":"48","author":"Khan","year":"2004","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371651630025X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371651630025X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T02:37:54Z","timestamp":1567737474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221371651630025X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":35,"alternative-id":["S221371651630025X"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2016.02.007","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low prevalence of clarithromycin-resistant Helicobacter pylori isolates with A2143G point mutation in the 23S rRNA gene in North India","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2016.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}